Important considerations in the design of iron oxide nanoparticles as contrast agents for TI-weighted MRI and MRA.
Kellar
Kenneth E
KE
Nycomed Amersham Imaging, Wayne, PA, USA.
Fujii
Dennis K
DK
Gunther
Wolfgang H H
WH
Briley-Saebø
Karen
K
Bjornerod
Atle
A
Spiller
Marga
M
Koenig
Seymour H
SH
D003287:Contrast Media / Q000737:chemistry*; D003911:Dextrans; D052203:Ferrosoferric Oxide; D007501:Iron / Q000737:chemistry*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009682:Magnetic Resonance Spectroscopy; D058185:Magnetite Nanoparticles; D010087:Oxides / Q000737:chemistry*
D003287:Contrast Media; D003911:Dextrans; D058185:Magnetite Nanoparticles; D010087:Oxides; C097921:ferumoxtran-10; D007501:Iron; D052203:Ferrosoferric Oxide